Search Within

James W Young

Formats
  1. Meeting Abstract (183)
  2. Journal Article (124)
  3. Research Letter (4)
  4. Conference Paper (3)
  5. Book Section (2)
  6. Editorial (2)
Groups
  1. Bone Marrow Transplant (318)
  2. Center for Hematologic Malignancies (318)
  3. Department of Medicine (318)
  4. Hematologic Malignancies, Division of (318)
  5. Sloan Kettering Institute Faculty (191)
  6. GSK Faculty (190)

More Groups

People
  1. Esperanza Papadopoulos (187)
  2. Hugo Castro-Malaspina (157)
  3. Ann Jakubowski (154)
  4. Richard O'Reilly (145)
  5. Miguel-Angel Perales (144)
  6. Sergio Giralt (118)

More People

Years
  1. 2025 (1)
  2. 2023 (5)
  3. 2022 (8)
  4. 2021 (7)
  5. 2020 (16)
  6. 2019 (5)

More Years

Publications
  1. Blood (125)
  2. Biology of Blood and Marrow Transplantation (81)
  3. Bone Marrow Transplantation (14)
  4. Journal of Immunology (8)
  5. Blood Advances (7)
  6. Leukemia and Lymphoma (6)

More Publications

Publishers
  1. American Society of Hematology (132)
  2. Elsevier Inc. (88)
  3. Nature Publishing Group (17)
  4. American Association for Cancer Research (9)
  5. The American Association of Immunologists, Inc (8)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (318)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • New insights into the phenotype of human dendritic cell populations
    Journal Article

    Clark, G. J.; Kupresanin, F.; Fromm, P. D.; Ju, X.; Muusers, L.; Silveira, P. A.; Elgundi, Z.; Gasiorowski, R. E.; Papadimitrious, M. S.; Bryant, C.; more...
    Clinical & Translational Immunology (2016)

    Fulltext@MSK | Save
  • Second allogeneic stem cell transplantation for acute leukemia using a chemotherapy- Only cytoreduction with clofarabine, melphalan, and thiotepa
    Journal Article

    Spitzer, B.; Perales, M. A.; Kernan, N. A.; Prockop, S. E.; Zabor, E. C.; Webb, N.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Scaradavou, A.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Long-term prognosis of one-year survivors of CD34-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis
    Meeting Abstract

    Cho, C.; Hsu, M.; Avecilla, S.; Barba, P.; Barker, J.; Castro-Malaspina, H.; Devlin, S.; Giralt, S.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • T-cell exhaustion in multiple myeloma relapse after autotransplant: Optimal timing of immunotherapy
    Journal Article

    Chung, D. J.; Pronschinske, K. B.; Shyer, J. A.; Sharma, S.; Leung, S.; Curran, S. A.; Lesokhin, A. M.; Devlin, S. M.; Giralt, S. A.; Young, J. W.
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with advanced myelodysplastic syndrome undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Proli, A. J.; Tamari, R.; Zheng, J.; Jakubowski, A. A.; Papadopoulos, E.; Ponce, D. M.; Devlin, S. M.; Sauter, C. S.; Perales, M. A.; Young, J. W.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save